Clinical Trials Currently Enrolling

Please contact the individual trial centers listed below for enrollment information. You may also click on the clinicaltrials.gov link for specific trial information.

Product Candidate	Location	Principal Investigator	Indication	Phase	Contact
ENMD-2076	Indiana University Melvin and Bren Simon Cancer Center	Sherif Farag, M.D.	Multiple Myeloma	I	Dr. Sherif Farag (317) 274-0843

Ongoing Trials, Enrollment Closed

Product Candidate	Location	Principal Investigator	Indication	Phase
MKC-1 with Pemetrexed	Multi-Center Trial	Dr. Nasser H. Hanna	Advanced Cancer and Non-Small Cell Lung Cancer (NSCLC)	I / II
MKC-1	Multi-center	Dr. Amit Oza	Ovarian/Endometrial Cancers	II
ENMD-2076	University of Colorado and Dana-Farber Cancer Institute	Dr. Wells Messersmith & Dr. Geoffrey Shaprio	Advanced Cancers	I
ENMD-2076	Princess Margaret Hospital	Dr. Karen Yee	Leukemia	I
ENMD-2076	Princess Margaret Hospital	Amit Oza, M.D.	Ovarian Cancer	II
ENMD-2076	Dana-Farber /Harvard Cancer Center	Ursula Matulonis, M.D.	Ovarian Cancer	II
ENMD-2076	Indiana University Melvin and Bren Simon Cancer Center	Daniela Matei, MD	Ovarian Cancer	II
ENMD-2076	University of Chicago Medical Center	Gini Fleming, MD	Ovarian Cancer	II
ENMD-2076	Memorial Sloan-Kettering Cancer Center	William Tew, MD	Ovarian Cancer	II
ENMD-2076	University of Colorado Cancer Center	Kian Behbakht, MD	Ovarian Cancer	II

Completed Trials

Product Candidate	Location	Principal Investigator	Indication	Phase
MKC-1	Princess Margaret Hospital	Dr. Karen Yee	Leukemia	I
Panzem® NCD w/ Temodar®	Preston Robert Tisch Brain Tumor Center at Duke University Medical Center	Dr. Annick Desjardins	Glioblastoma Multiforme (GBM)	II
Panzem® NCD	Multi-Center Trial	Dr. Glenn Liu	Renal Cell Carcinoma	II
Panzem® NCD	Multi-Center Trial	Dr. Glenn Liu	Hormone-Refractory Prostate Cancer	II
MKC-1	Multi-Center Trial		Advanced and Metastatic Breast Cancer	II
Panzem® NCD	Duke University Medical Center	Dr. Kimberly L. Blackwell	Metastatic Breast Cancer	Ib
Panzem® NCD	Indiana University Cancer Center, Indianapolis, IN	Dr. Christopher J. Sweeney	Advanced Cancer	Ib (Part B)
ENMD-1198	University of Colorado Cancer Center, Aurora, CO	Dr. Ross Camidge	Advanced Cancer	I
Panzem® NCD	Dana-Farber Cancer Institute, Boston, Massachusetts	Dr. Matthew Kulke	Carcinoid Cancer	II
Panzem® NCD	University of Wisconsin Comprehensive Cancer Center (UWCCC), Madison, WI	Dr. George Wilding	Advanced Cancer	Ib (Part B)
Panzem® NCD	Multi-Center Trial	Dr. Daniela E. Matei	Ovarian Cancer	II
Panzem® NCD	Brain Tumor Center at Duke University Medical Center, Durham, NC	Dr. David A. Reardon	Brain Cancer	II
Panzem® NCD	University of Wisconsin Comprehensive Cancer Center (UWCCC), Madison, WI	Dr. George Wilding	Advanced Cancer	Ib (Part A)
Panzem® NCD	Indiana University Cancer Center, Indianapolis, IN	Dr. Christopher J. Sweeney	Advanced Cancer	Ib (Part A)
Panzem® Capsules	Mayo Clinic, Rochester, MN	Dr. Vincent Rajkumar	Multiple Myeloma	II
Panzem® Capsules	Dana-Farber Cancer Institute, Boston, MA	Dr. Paul Richardson	Multiple Myeloma	II
Panzem® Capsules *	National Cancer Institute, Bethesda, MD	Dr. William D. Figg, Dr. William Dahut	Advanced Solid Tumors	I
Panzem® Capsules **	Mayo Clinic, Rochester, MN	Dr. Charles Erlichman	Advanced Solid Tumors	I
Panzem® Capsules	University of Wisconsin, Madison, WI	Dr. George Wilding	Prostate Cancer	II
Panzem® Capsules	Indiana University Cancer Center, Indianapolis, IN	Dr. Chris Sweeney, Dr. George Sledge	Prostate Cancer	II
Panzem® Capsules	Indiana University Cancer Center, Indianapolis, IN	Dr. Kathy Miller , Dr. George Sledge	Metastatic Breast Cancer	I
Panzem® Capsules w/ Taxotere®	Indiana University Cancer Center, Indianapolis, IN	Dr. Kathy Miller , Dr. George Sledge	Metastatic Breast Cancer	I
MKC-1	Multi-center	Dr. Eunice Kwak	Pancreatic Cancer	II
MKC-1	University of Wisconsin	Glenn Liu, M.D.	Advanced Cancer	I

* NCI-sponsored trial. EntreMed provided only the study drug for this trial.
** NCI-sponsored trial. EntreMed provided only the study drug for this trial.